Search for: "ASTRAZENECA LP"
Results 41 - 60
of 138
Sort by Relevance
|
Sort by Date
17 Jul 2012, 4:40 am
See AstraZeneca LP v. [read post]
9 Jul 2012, 7:41 pm
Karst – In a decision that, unless appealed, marks the end of AstraZeneca Pharmaceuticals LP’s (“AstraZeneca’s”) battle with FDA over the approval of generic versions of the company’s blockbuster antipsychotic drug SEROQUEL (quetiapine fumarate) Tablets, the U.S. [read post]
15 Jun 2012, 12:19 pm
AstraZeneca LP, 2009 WL 1610575 at 8 (Del. [read post]
25 May 2012, 11:32 am
Judge Stark cited the Federal Circuit’s recent decision in AstraZeneca Pharmaceuticals LP v. [read post]
24 May 2012, 4:23 am
Astrazeneca LP, 2010 WL 3706584, at *6 (Del. [read post]
16 May 2012, 12:22 pm
AstraZeneca Pharmaceuticals, LP, 634 F.3d 1352, 1360-66 (11th Cir. 2011) (plaintiff had not pleaded recoverable economic injury); Polk v. [read post]
20 Apr 2012, 10:36 am
McGrath In its recent decision in AstraZeneca Pharmaceuticals LP v. [read post]
16 Apr 2012, 1:29 am
District Court are Motions for Summary Judgment filed by FDA and AstraZeneca Pharmaceuticals LP (here and here) concerning FDA’s approval of ANDAs for generic versions of SEROQUEL (quetiapine fumarate) Tablets and the Agency’s decision, discussed in a March 27, 2012 Letter Decision, concerning the scope and applicability of 3-year marketing exclusivity in that case. [read post]
29 Mar 2012, 5:47 am
District Court for the District of Columbia denied AstraZeneca Pharmaceuticals LP’s (“AstraZeneca’s”) Motion for Temporary Restraining Order (Complaint here) seeking to vacate FDA’s March 27, 2012 approval of more than 10 ANDAs for generic versions of AstraZeneca’s blockbuster antipsychotic drug SEROQUEL (quetiapine fumarate) Tablets (NDA No. 020639), and to enjoin FDA from granting any further final ANDA approvals for the drug… [read post]
27 Mar 2012, 8:51 am
No. 10-915-LPS (D. [read post]
26 Mar 2012, 1:43 am
District Court for the District of Columbia denied AstraZeneca Pharmaceuticals LP’s (“AstraZeneca’s”) Application for Prelimiary Injunction and dismissed without prejudice the action AstraZeneca filed on March 12, 2012 seeking to enjoing FDA from granting final ANDA approval for a generic version of the company’s blockbuster antipsychotic drug SEROQUEL (quetiapine fumarate) Tablets (NDA No. 020639) as early as March 26, 2012 (as well… [read post]
25 Mar 2012, 9:25 pm
Mylan Laboratories Ltd, et al. 3:12-cv-01378; filed March 6, 2012 in the District Court of New Jersey • Plaintiffs: Astrazeneca AB; Aktiebolaget Hassle; Astrazeneca LP; KBI... [read post]
24 Mar 2012, 1:20 pm
AstraZeneca Pharmaceuticals LP to surprise, and unpleasantly upend the patentee. [read post]
6 Mar 2012, 1:00 am
In AstraZeneca Pharmaceuticals LP v. [read post]
27 Feb 2012, 3:30 am
AstraZeneca Pharmaceuticals, LP, No. 1:10CV104-SA-JAD, 2010 WL 3951906 (N.D. [read post]
23 Feb 2012, 8:46 pm
By Andrew Williams -- Last week, in AstraZeneca Pharmaceutical LP v. [read post]
13 Feb 2012, 1:47 pm
LP. v. [read post]
13 Feb 2012, 12:54 pm
No. 10-915-LPS (D. [read post]
9 Feb 2012, 3:43 pm
LP v. [read post]
9 Jan 2012, 10:13 am
AstraZeneca Pharmaceuticals LP, 2-11-cv-00807 (SCD January 4, 2012, Order) (Austin, M.J.) [read post]
